PAHC — Phibro Animal Health Balance Sheet
0.000.00%
- $1.54bn
- $2.19bn
- $1.52bn
Annual balance sheet for Phibro Animal Health, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | 2026 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 91.2 | 81.3 | 115 | 77 | 82 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 167 | 163 | 169 | 228 | 239 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 566 | 586 | 601 | 811 | 936 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 203 | 231 | 241 | 396 | 421 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 932 | 971 | 982 | 1,361 | 1,501 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 191 | 176 | 204 | 293 | 316 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 669 | 689 | 726 | 1,075 | 1,116 |
| Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 262 | 283 | 257 | 286 | 385 |
| Total Liabilities & Shareholders' Equity | 932 | 971 | 982 | 1,361 | 1,501 |
| Total Common Shares Outstanding |